NCT01556711

Brief Summary

The objectives of the study are to document device performance with respect to the primary and secondary endpoints.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
816

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 16, 2012

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

December 10, 2013

Status Verified

December 1, 2013

Enrollment Period

1.1 years

First QC Date

March 5, 2012

Last Update Submit

December 7, 2013

Conditions

Keywords

Head InjuryHead TraumaTBI (Traumatic Brain Injury)Emergency Department

Outcome Measures

Primary Outcomes (1)

  • Structural Brain Injury Assessment

    Using a BrainScope classification algorithm, the Ahead® M-100 will identify subjects showing sensitivities among 3 classes: Green - brain electrical activity that is consistent with patients without head injuries (Ahead® M-100 output = 1), Yellow - brain electrical activity that is consistent with head injured subjects who are abnormal, but do not have a structural brain injury (Ahead® M-100 output = 2 or 3), Red - brain electrical activity consistent with a structural brain injury observable on CT (Ahead® M-100 output = 4).

    within 24 hours of injury

Secondary Outcomes (1)

  • Functional Brain Injury Assessment

    within 24 hours of injury

Study Arms (2)

Head Injury

Males and females ages 18 to 80 (the entire age range), who are admitted to the ED, who are suspected of a traumatically induced structural brain

Control

A 'normal' control group will be recruited for comparison and will consist of ED patients ("ED normal control group) who have sustained an injury but do not exhibit any trauma above the clavicle and no history of MVA requiring an ED visit or TBI within the past one (1) year, and no primary complaint of syncope

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who enter the ED at hospitals that are participating as clinical sites for this study

You may qualify if:

  • Males and females ages 18 to 80 (the entire age range), who are admitted to the Emergency Department (ED), who are suspected of a traumatically induced structural brain injury and/or clinical manifestations of functional brain injury, as a result of insult to the head from an external force, e.g., the head being struck by an object, the head striking an object, the head being exposed to forces generated from a blast or explosion, and/or the brain undergoing an acceleration/deceleration movement without direct external trauma to the head with a Glasgow Coma Scale of \> 8.
  • The acute, suspected traumatically induced structural brain injury and/or clinical manifestations of functional brain injury will have occurred within the past 24 hours upon admission to the ED.
  • The ED normal control group will be males and females ages 18 to 80 (the entire age range), who are admitted to the ED for presenting complaints that do not involve the head or neck (no trauma above the clavicles) and no history of MVA requiring an ED visit or TBI within the past one (1) year, and no primary complaint of syncope

You may not qualify if:

  • Subjects will be excluded who have forehead, scalp, or skull abnormalities or other conditions that would prevent correct application of the electrode headset on the skin.
  • In addition, subjects with dementia, Parkinson's Disease, multiple sclerosis, seizure disorder, brain tumors, history of brain surgery, mentally retarded, psychiatric disorder for which there is a prescribed psychiatric medication taken on a daily basis, substance dependence, history of TIA or stroke within the last year, currently receiving dialysis or in end-stage renal disease, active fever defined as greater than 100oF or 37.7oC, current condition is listed as "critical" in the opinion of the investigator, subject is suffering from an open head injury, subject requires advanced airway management (i.e. mechanical ventilation), currently receiving procedural sedation medications (e.g. benzodiazepine, anesthetic, NMDA receptor antagonist, or opioid agonist), subjects below the age of 18 years, pregnant women, and prisoners will not be eligible for study.
  • ED normal control subjects will be excluded if there is a suspected neck injury or trauma above the clavicles, a primary complaint of generalized weakness, or a primary complaint of headache or migraine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Hartford Hospital

Hartford, Connecticut, 06102-5037, United States

Location

University of Maryland R Cowley Shock Trauma Center

Baltimore, Maryland, 21204, United States

Location

Sinai Hospital

Baltimore, Maryland, 21215, United States

Location

Wayne State University - Detroit Receiving Hospital

Detroit, Michigan, 48201, United States

Location

Wayne State University - Sinai Grace Hospital

Detroit, Michigan, 48235, United States

Location

Washington University - Barnes Jewish Hospital

St Louis, Missouri, 63110, United States

Location

University of Rochester Medical Center

Rochester, New York, 14620, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Brooke Army Medical Center

Fort Sam Houston, Texas, 78234-6200, United States

Location

University of Virginia Medical Center

Charlottesville, Virginia, 22908-2877, United States

Location

INOVA Health System

Fairfax, Virginia, 22042, United States

Location

Related Publications (4)

  • Naunheim RS, Treaster M, English J, Casner T. Automated electroencephalogram identifies abnormalities in the ED. Am J Emerg Med. 2011 Oct;29(8):845-8. doi: 10.1016/j.ajem.2010.03.010. Epub 2010 May 1.

    PMID: 20825903BACKGROUND
  • Naunheim RS, Treaster M, English J, Casner T, Chabot R. Use of brain electrical activity to quantify traumatic brain injury in the emergency department. Brain Inj. 2010;24(11):1324-9. doi: 10.3109/02699052.2010.506862.

    PMID: 20722504BACKGROUND
  • Naunheim RS, Casner T. Novel method for detecting brain abnormality in a patient with epidural hematoma: a case report. Am J Emerg Med. 2010 Mar;28(3):386.e1-2. doi: 10.1016/j.ajem.2009.05.008.

    PMID: 20223405BACKGROUND
  • McCrea M, Prichep L, Powell MR, Chabot R, Barr WB. Acute effects and recovery after sport-related concussion: a neurocognitive and quantitative brain electrical activity study. J Head Trauma Rehabil. 2010 Jul-Aug;25(4):283-92. doi: 10.1097/HTR.0b013e3181e67923.

    PMID: 20611046BACKGROUND

MeSH Terms

Conditions

Brain InjuriesCraniocerebral TraumaBrain Injuries, TraumaticEmergencies

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Robert A De Lorenzo, MD

    Brooke Army Medical Center

    PRINCIPAL INVESTIGATOR
  • Peter Cuenca, MD

    Brooke Army Medical Center

    PRINCIPAL INVESTIGATOR
  • Samuel M Galvagno, DO

    University of Maryland R. Cowley Shock Trauma Center

    PRINCIPAL INVESTIGATOR
  • Stephen J Huff, MD

    University of Virginia Medical Center

    PRINCIPAL INVESTIGATOR
  • Rosanne Naunheim, MD

    Washington University - Barnes Jewish Hospital

    PRINCIPAL INVESTIGATOR
  • Brian O'Neil, MD

    Wayne State University - Detroit Receiving Hospital

    PRINCIPAL INVESTIGATOR
  • Brian J O'Neil, MD

    Wayne State University - Sinai Grace Hospital

    PRINCIPAL INVESTIGATOR
  • Sandeep Johar, DO

    Hartford Hospital

    PRINCIPAL INVESTIGATOR
  • Bradley Kolls, MD

    Duke University Medical Cetner

    PRINCIPAL INVESTIGATOR
  • Jeffrey Bazarian, MD

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • James Ecklund, MD

    Inova Fairfax Hospital

    PRINCIPAL INVESTIGATOR
  • Kevin Crutchfield, MD

    Sinai Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2012

First Posted

March 16, 2012

Study Start

August 1, 2012

Primary Completion

September 1, 2013

Study Completion

September 1, 2013

Last Updated

December 10, 2013

Record last verified: 2013-12

Locations